(Q37801547)

23 August 2017

Sensitivity estimates of blood-based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease (English)

1 reference

23 August 2017

1 reference

1 reference

4

1 reference

23 August 2017

Ulrike Haug

3

0 references

author name string

Sha Tao

series ordinal

1

1 reference

PubMed ID

20959816

23 August 2017

Sabrina Hundt

series ordinal

2

1 reference

PubMed ID

20959816

23 August 2017

language of work or name

English

0 references

publication date

19 October 2010

1 reference

The American Journal of Gastroenterology

23 August 2017

1 reference

23 August 2017

106

1 reference

23 August 2017

242-253

1 reference

23 August 2017

2

1 reference

Global cancer statistics, 2002

23 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Blood markers for early detection of colorectal cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: Estimates based on 1,875,708 screening colonoscopies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Failure of CA19-9 to detect asymptomatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Estimating the probability of cancer with several tumor markers in patients with colorectal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Preoperative serum levels of CEA and CA 242 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Detection and monitoring of serum p53 antibodies in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Prognostic value of soluble P-selectin levels in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: prognostic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

DNA methylation biomarkers for blood-based colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

Monoclonal antibody 4D3 detects small intestinal mucin antigen (SIMA)—Glycoprotein in the serum of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.393

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.393

1 reference

23 August 2017

1 reference

PubMed ID

20959816